SCHEDULE: Orca Capital AG Discloses 4.6% Stake in Co-Diagnostics

Orca Capital AG has reported a 4.6% beneficial ownership stake in Co-Diagnostics, Inc., holding 2,193,713 shares of common stock.

Summary

• Orca Capital AG, a German entity, filed an Amendment No. 1 to Schedule 13G regarding its ownership in Co-Diagnostics, Inc.
• The filing indicates beneficial ownership of 2,193,713 shares of Co-Diagnostics, Inc. Common Stock.
• This represents 4.6% of the issuer's outstanding common stock.
• The percentage is calculated based on an aggregate of 48,142,582 shares outstanding immediately after the completion of Co-Diagnostics' registered offering on September 18, 2025.
• Orca Capital AG holds sole voting power and sole dispositive power over all 2,193,713 shares.
• The filing certifies that the securities were not acquired or held for the purpose of changing or influencing control of the issuer.

Sentiment

Score: 6

Explanation: The disclosure of a significant passive stake by an institutional investor like Orca Capital AG is generally a neutral to slightly positive signal, indicating some level of confidence in the company without implying active engagement in management or control.

Positives

• A significant institutional investor, Orca Capital AG, has disclosed a substantial stake, potentially indicating confidence in Co-Diagnostics, Inc.
• Orca Capital AG holds sole voting and dispositive power over its 4.6% stake, suggesting direct control over its investment decisions.

Future Outlook

NA

Management Comments

• Orca Capital AG certifies that the securities were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of Co-Diagnostics, Inc., nor were they acquired or held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11.

Industry Context

NA

Stakeholder Impact

• Shareholders: Increased transparency regarding institutional ownership and potential long-term investor confidence.

Key Dates

Recommendation

This filing is a routine disclosure of a passive ownership stake by an institutional investor. It does not contain new financial performance data, strategic updates, or significant changes that would warrant a 'buy' or 'sell' recommendation. The presence of an institutional investor like Orca Capital AG holding a 4.6% stake is a neutral to slightly positive indicator, suggesting continued investor interest, but it doesn't provide a strong catalyst for a change in investment thesis. Therefore, a 'hold' recommendation is appropriate based solely on this filing.

Keywords

Co-Diagnostics Inc., Orca Capital AG, Schedule 13G, Beneficial Ownership, Common Stock, Institutional Investor, Equity Stake, 189763105